Elevated plasma factor VIII in a mouse model of low-density lipoprotein receptor-related protein deficiency

Blood

Volumn 101, Issue 10, 2003, Pages 3933-3939

  Bovenschen, Niels ^b   Herz, Joachim ^b   Grimbergen, Jos M ^b   Lenting, Peter J ^b   Havekes, Louis M ^b   Mertens, Koen ^a   Van Vlijmen, Bart J M ^b  

^a SANQUIN RESEARCH   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 8; LOW DENSITY LIPOPROTEIN RECEPTOR; PROTEIN; RECEPTOR ASSOCIATED PROTEIN; UNCLASSIFIED DRUG; VASOPRESSIN DERIVATIVE; VON WILLEBRAND FACTOR; MEGALIN;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD CLOTTING TIME; COMPARATIVE STUDY; CONTROLLED STUDY; EXPERIMENTAL TEST; FEMALE; GENE TRANSFER; GENETIC STRAIN; IN VIVO STUDY; MOUSE; NONHUMAN; PHYSIOLOGY; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; REGULATORY MECHANISM; THROMBOCYTOSIS; ANIMAL; C57BL MOUSE; DISEASE MODEL; GENE VECTOR; GENETICS; GENOTYPE; HUMAN; KINETICS; METABOLISM; MOUSE MUTANT; MOUSE STRAIN;

ADENOVIRIDAE; ANIMALS; DISEASE MODELS, ANIMAL; FACTOR VIII; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; GENOTYPE; HUMANS; KINETICS; LDL-RECEPTOR RELATED PROTEIN 2; MICE; MICE, INBRED C57BL; MICE, INBRED STRAINS; MICE, KNOCKOUT; VON WILLEBRAND FACTOR;

EID: 0037926885     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2002-07-2081     Document Type: Article

References (51)

1. Mann KG, Nesheim ME, Church WR, Haley P, Krishnaswamy S. Surface-dependent reactions of the vitamin K-dependent enzyme complexes. Blood. 1990;76:1-16.
2. Lenting PJ, van Mourik JA, Mertens K. The life cycle of coagulation factor VIII in view of its structure and function. Blood. 1998;92:3983-3996.
3. Wion KL, Kelly D, Summerfield JA, Tuddenham EGD, Lawn RM. Distribution of factor VIII mRNA and antigen in human liver and other tissues. Nature. 1985;317:726-729.
4. Hollestelle MJ, Thinnes T, Crain K, et al. Tissue distribution of factor VIII gene expression in vivo: a closer look. Thromb Haemost. 2001;86:855-861.
5. Sadler JE. Biochemistry and genetics of von Willebrand factor. Annu Rev Biochem. 1998;67:395-424.
6. Lollar P, Hill-Eubanks DC, Parker CG. Association of the factor VIII light chain with von Willebrand factor. J Biol Chem. 1988;266:10451-10455.
7. Weiss HJ, Sussman II, Hoyer LW. Stabilization of factor VIII in plasma by the von Willebrand factor. J Clin Invest. 1977;60:390-404.
8. Eaton D, Rodriquez H, Vehar GA. Proteolytic processing of human factor VIII: correlation of specific cleavages by thrombin, factor Xa, and activated protein C with activation and inactivation of factor VIII coagulant activity. Biochemistry. 1986; 25:505-512.
9. Curtis JE, Helgerson SL, Parker ET, Lollar P. Isolation and characterization of thrombin-activated human factor VIII. J Biol Chem. 1994;269:6246-6251.
10. Fay PJ, Smudzin TM, Walker FJ. Activated protein C-catalyzed inactivation of human factor VIII and factor Villa. J Biol Chem. 1991;266:20139-20145.
11. Lenting PJ, Neels JG, van den Berg BMM, et al. The light chain of factor VIII comprises a binding site for low density lipoprotein receptor-related protein. J Biol Chem. 1999;274:23734-23739.
12. Saenko EL, Yakhyaev AV, Mikhalienko I, Strickland DK, Sarafanov AG. Role of the low density lipoprotein-related protein receptor in mediation of factor VIII catabolism. J Biol Chem. 1999;274: 37685-37692.
13. Sarafanov AG, Ananyeva NM, Shima M, Saenko EL. Cell surface heparan sulfate proteoglycans participate in factor VIII catabolism mediated by low density lipoprotein receptor-related protein. J Biol Chem. 2001;276:11970-11979.
14. Strickland DK, Kounnas MZ, Argraves WS. LDL receptor-related protein: a multiligand receptor for lipoprotein and proteinase catabolism. FASEB J. 1995;9:890-898.
15. Moestrup SK, Gliemann J, Pallesen G. Distribution of the alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein in human tissues. Cell Tissue Res. 1992;269:375-382.
16. Neels JG, Hom IR, van den Berg BMM, Pannekoek H, van Zonneveld AJ. Ligand-receptor interactions of the low density lipoprotein receptor-related protein, a multi-ligand endocytic receptor. Fibrinol Proteolysis. 1998;12:219-240.
17. Herz J, Goldstein JL, Strickland DK, Ho YK, Brown MS. 39-kDa protein modulates binding of ligands to low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor. J Biol Chem. 1991;266:21232-21238.
18. Bu G, Schwartz AL, RAP, a novel type of ER chaperone. Trends Cell Biol. 1998;8:272-276.
19. Neels JG, Bovenschen N, van Zonneveld AJ, Lenting PJ. Interaction between factor VIII and LDL receptor-related protein: modulation of coagulation? Trends Cardiovasc Med. 2000;10:8-14.
20. Turecek PL, Schwarz HP, Binder BR. In vivo inhibition of low density lipoprotein receptor-related protein improves survival of factor VIII in the absence of von Willebrand factor [letter]. Blood. 2000;95:3637.
21. Schwarz HP, Lenting PJ, Binder B, et al. Involvement of low-density lipoprotein receptor-related protein (LRP) in the clearance of factor VIII in von Willebrand factor-deficient mice. Blood. 2000;95: 1703-1708.
22. Yamamoto T, Davis CG, Brown MS, et al. The human LDL receptor: a cysteine-rich protein with multiple Alu sequences in its mRNA. Cell. 1984; 39:27-38.
23. Sakai J, Hoshino A, Takahashi S, et al. Structure, chromosome location, and expression of the human very low density lipoprotein receptor gene. J Biol Chem. 1994;269:2173-2182.
24. Kim DH, Iijima H, Goto K, et al. Human apolipoprotein E receptor 2: a novel lipoprotein receptor of the low density lipoprotein receptor family predominantly expressed in brain. J Biol Chem. 1996;271:8373-8380.
25. Hjalm G, Murray E, Crumley G, et al. Cloning and sequencing of human gp330, a Ca(2+)-binding receptor with potential intracellular signaling properties. Eur J Biochem. 1996;239:132-137.
26. Rohlman A, Gotthardt M, Hammer RE, Herz J. Inducible inactivation of hepatic LRP gene by cremediated recombination confirms role of LRP in clearance of chylomicron remnants. J Clin Invest. 1998;101:689-695.
27. van Vlijmen BJM, Rohlmann A, Page ST, et al. An extrahepatic receptor-associated protein-sensitive mechanism is involved in the metabolism of triglyceride-rich lipoproteins. J Biol Chem. 1999; 274:35219-35226.
28. Rohlmann A, Gotthardt M, Willnow TE, Hammer RE, Herz J. Sustained somatic gene inactivation by viral transfer of Cre recombinase. Nat Biotechnol. 1996;14:1562-1565.
29. Lenting PJ, Donath MJSH, van Mourik JA, Mertens K. Identification of a binding site for blood coagulation factor IXa on the light chain of human factor VIII. J Biol Chem. 1994;269:7150-7155.
30. Björkman S, Carlsson M. The pharmacokinetics of factor VIII and factor IX: methodology, pitfalls and applications. Haemophilia. 1997;3:1-8.
31. Willnow TE, Sheng Z, Ishibashi S, Herz J. Inhibition of hepatic chylomicron remnant uptake by gene transfer of a receptor antagonist. Science. 1994;264:1471-1474.
32. Neels JG, van den Berg BMM, Mertens K, et al. Activation of factor IX zymogen results in exposure of a binding site for low-density lipoprotein receptor-related protein. Blood. 2000;96:3459-3465.
33. Denis C, Methia N, Frenette PS, et al. A mouse model of severe von Willebrand disease: defects in hemostasis and thrombosis. Proc Natl Acad Sci U S A. 1998;95:9524-9529.
34. Schwarz HP, Turecek PL, Pichler L, et al. Recombinant von Willebrand factor. Thromb Haemost. 1997;78:571-576.
35. Begbie M, Notley C, Tinlin S, Sawyer L, Lillicrap D. The factor VIII acute phase response requires the participation of NFκB and C/EBP. Thromb Haemost. 2000;84:216-222.
36. Over J, Sixma JJ, Bruine MH, et al. Survival of 125iodine-labeled factor VIII in normals and patients with classic hemophilia: observations on the heterogeneity of human factor VIII. J Clin Invest. 1978;62:223-234.
37. Mordenti J, Osaka G, Garcia K, Thomsen K, Licko V, Meng G. Pharmacokinetics and interspecies scaling of recombinant human factor VIII. Toxicol Appl Pharmacol. 1996;136:75-78.
38. Morfini M, Mannucci PM, Tenconi PM, et al. Pharmacokinetics of monoclonally-purified and recombinant factor VIII in patients with severe von Willebrand disease. Thromb Haemost. 1993;70:270-272.
39. Denis CV, Kwack K, Saffaripour S, et al. Interleukin 11 significantly increases plasma von Willebrand factor and factor VIII in wild type and von Willebrand disease mouse models. Blood. 2001; 97:465-472.
40. Kaufman RJ, Dorner AJ, Fass DN. Von Willebrand factor elevates plasma factor VIII without induction of factor VIII messenger RNA in the liver. Blood. 1999;93:193-197.
41. Do H, Healey JF, Waller EK, Lollar P. Expression of factor VIII by murine liver sinusoidal endothelial cells. J Biol Chem. 1999;274:19587-19592.
42. Twisk J, Gillian-Daniel DL, Tebon A, Wang L, Barret PH, Attie AD. The role of the LDL receptor in apolipoprotein B secretion. J Clin Invest. 2000; 105:521-532.
43. Gillian-Daniel DL, Bates PW, Tebon A, Attie AD. Endoplasmic reticulum localization of the low density lipoprotein receptor mediates presecretory degradation of apolipoprotein B. Proc Natl Acad Sci U S A. 2002;99:4337-4342.
44. Warshawsky I, Bu G, Schwartz AL. 39-kD protein inhibits tissue-type plasminogen activator clearance in vivo. J Clin Invest. 1993;92:937-944.
45. Kuhn R, Schwenk F, Aguet M, Rajewsky K. Inducible gene targeting in mice. Science. 1995;269: 1427-1429.
46. Sousa MM, Saraiva MJ. Internalization of transthyretin: evidence of a novel yet unidentified receptor-associated protein (RAP)-sensitive receptor. J Biol Chem. 2001;276:14420-14425.
47. Birn H, Verroust PJ, Nexo E, et al. Characterization of an epithelial approximately 460-kDa protein that facilitates endocytosis of intrinsic factor-vitamin B12 and binds receptor-associated protein. J Biol Chem. 1997;272:26497-26504.
48. Koster T, Blann AD, Briet E, Vandenbroucke JP, Rosendaal FR. Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis. Lancet. 1995;334:152-155.
49. Hobbs HH, Russell DW, Brown MS, Goldstein JL. The LDL receptor locus in familial hypercholesterolemia: mutational analysis of a membrane protein. Annu Rev Genet. 1990;24:133-170.
50. Klovisto UM, Palvimo JJ, Janne OA, Kontula K. A single-based substitution in the proximal Sp1 site of the human low density lipoprotein receptor promotor as a cause of heterozygous familial hypercholesterolemia. Proc Natl Acad Sci U S A. 1994; 91:10526-10530.
51. Blacklow SC, Kim PS. Protein folding and calcium binding defects arising from familial hypercholesterolemia mutations of the LDL receptor [letter]. Nat Struct Biol. 1996;3:758-762.